January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the ...
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Operator Welcome to the Bristol Myers Squibb fourth quarter 2024 earnings conference call. [Operator instructions] Please note this event is being recorded. I would now like to turn the conference ...
A digital therapeutic platform and spinout from The University of Manchester that focuses on tackling severe mental illness ...
A digital therapeutic platform and spinout from The University of Manchester that focuses on tackling severe mental illness ...
Live Science on MSN10h
Massive study of 3 million people reveals genetic 'hotspots' linked to bipolar disorderScientists have pinpointed nearly 300 "hotspots" in the human genome that may increase the risk of bipolar disorder. In the ...
Do you know what bipolar disorder involves? Are you sure? Psychiatrist David Medina helps separates the myths from the facts.
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
Bristol-Myers Squibb (NYSE:BMY) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback